Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-09

Clinical Trial Update: Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study

View source ↗

Summary

This completed cross-sectional clinical study from Nanjing assesses antibiotic resistance patterns of Helicobacter pylori isolates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: HELICOBACTER PYLORI INFECTIONS | Status: COMPLETED